de Montalembert M, Frangoul H. Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial". Haematologica; https://doi.org/10.3324/haematol.2026.301370 [Early view].